The relevance of theobromine for the beneficial effects of cocoa consumption

Frontiers in Pharmacology

Volumn 6, Issue FEB, 2015, Pages

  Martínez Pinilla, Eva ^a   Oñatibia Astibia, Ainhoa ^b   Franco, Rafael ^c  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Official College of Pharmacists of Gipuzkoa   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Adenosine receptor; Caffeine; Cocoa; Neurological disease; Receptor antagonist; Theobromine

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; CAFFEINE; PLACEBO; THEOBROMINE;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRONCHITIS; CACAO; CLINICAL TRIAL (TOPIC); COFFEE; COUGHING; DRUG ACTIVITY; DRUG CAPSULE; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; FOOD INTAKE; GENE EXPRESSION; HEART PROTECTION; HUMAN; NONHUMAN; OXIDATIVE STRESS; RECEPTOR BLOCKING; UNSPECIFIED SIDE EFFECT;

EID: 84926453467     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2015.00030     Document Type: Article

References (59)

1. Ahmad, S. F., Zoheir, K. M., Ansari, M. A., Korashy, H. M., Bakheet, S. A., Ashour, A. E., et al. (2015). The role of poly(ADP-ribose) polymerase-1 inhibitor in carrageenan-induced lung inflammation in mice. Mol. Immunol. 63, 394-405. doi: 10.1016/j.molimm.2014.09.009
2. Baba, S., Osakabe, N., Kato, Y., Natsume, M., Yasuda, A., Kido, T., et al. (2007). Continuous intake of polyphenolic compounds containing cocoa powder reduces LDL oxidative susceptibility and has beneficial effects on plasma HDL-cholesterol concentrations in humans. Am. J. Clin. Nutr. 85, 709-717.
3. Baggott, M. J., Childs, E., Hart, A. B., De Bruin, E., Palmer, A. A., Wilkinson, J. E., et al. (2013). Psychopharmacology of theobromine in healthy volunteers. Psychopharmacology (Berl) 228, 109-118. doi: 10.1007/s00213-013-3021-0
4. Becker, A. B., Simons, K. J., Gillespie, C. A., and Simons, F. E. (1984). The bronchodilator effects and pharmacokinetics of caffeine in asthma. N. Engl. J. Med. 310, 743-746. doi: 10.1056/NEJM198403223101202
5. Bittencourt, L. S., Machado, D. C., Machado, M. M., Dos Santos, G. F. F., Algarve, T. D., Marinowic, D. R., et al. (2013). The protective effects of guaraná extract (Paullinia cupana) on fibroblast NIH-3T3 cells exposed to sodium nitroprusside. Food Chem. Toxicol. 53, 119-125. doi: 10.1016/j.fct.2012.11.041
6. Bonati, M., Latini, R., Sadurska, B., Riva, E., Galletti, F., Borzelleca, J. F., et al. (1984). Kinetics and metabolism of theobromine in male rats. Toxicology 30, 327-341. doi: 10.1016/0300-483X(84)90143-4
7. Chen, J. F., and Chern, Y. (2011). Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies. Handb. Exp. Pharmacol. 200, 267-310. doi: 10.1007/978-3-642-13443-2_10
8. Choi, O. H., Shamim, M. T., Padgett, W. L., and Daly, J. W. (1988). Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors. Life Sci. 43, 387-398. doi: 10.1016/0024-3205(88)90517-6
9. Ciruela, F., Casadó, V., Rodrigues, R. J., Luján, R., Burgueño, J., Canals, M., et al. (2006). Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J. Neurosci. 26, 2080-2087. doi: 10.1523/JNEUROSCI.3574-05.2006
10. Cortijo, J., Bou, J., Beleta, J., Cardelús, I., Llenas, J., Morcillo, E., et al. (1993). Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchus. Br. J. Pharmacol. 108, 562-568. doi: 10.1111/j.1476-5381.1993.tb12841.x
11. Costa, J., Lunet, N., Santos, C., Santos, J., and Vaz-Carneiro, A. (2010). Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies. J. Alzheimers. Dis. 20(Suppl. 1), S221-S238. doi: 10.3233/JAD-2010-091525
12. Cronstein, B. N., Montesinos, M. C., and Weissmann, G. (1999). Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. Proc. Natl. Acad. Sci. U.S.A. 96, 6377-6381. doi: 10.1073/pnas.96.11.6377
13. Eskelinen, M. H., Ngandu, T., Tuomilehto, J., Soininen, H., and Kivipelto, M. (2011). Midlife healthy-diet index and late-life dementia and Alzheimer's disease. Dement. Geriatr. Cogn. Dis. Extra 1, 103-112. doi: 10.1159/000327518
14. Gattuso, G., Manfredib, G., and Sammartanob, S. (2011). Quantitative study on the non-covalent interactions between ATP and caffeine, theophylline and theobromine in aqueous solution. Fluid Phase Equilibria. 308, 47-54. doi: 10.1016/j.fluid.2011.06.006
15. Geraets, L., Moonen, H. J., Wouters, E. F., Bast, A., and Hageman, G. J. (2006). The role of poly(ADP-ribose) polymerase-1 inhibitor in carrageenan-induced lung inflammation in mice. Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations. Biochem. Pharmacol. 72, 902-910. doi: 10.1016/j.bcp.2006.06.023
16. Gil, M., Skopinska-Rózewska, E., Radomska, D., Demkow, U., Skurzak, H., Rochowska, M., et al. (1993). Effect of purinergic receptor antagonists suramin and theobromine on tumor-induced angiogenesis in BALB/c mice. Folia Biol. (Praha) 39, 63-68
17. Gu, L., Gonzalez, F. J., Kalow, W., and Tang, B. K. (1992). Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics 2, 73-77. doi: 10.1097/00008571-199204000-00004
18. Haller, S., Montandon, M. L., Rodriguez, C., Moser, D., Toma, S., Hofmeister, J., et al. (2014). Acute caffeine administration effect on brain activation patterns in mild cognitive impairment. J. Alzheimers. Dis. 41, 101-112. doi: 10.3233/JAD-132360
19. Harris, E., Schulzke, S. M., and Patole, S. K. (2010). Pentoxifylline in preterm neonates: a systematic review. Paediatr. Drugs 12, 301-311. doi: 10.2165/11532600-000000000-00000
20. Hillyard, P. A., Nials, A. T., Skidmore, I. F., and Vardey, C. J. (1984). Characterization of the adenosine receptor responsible for the inhibition of histamine and SRS-A release from human lung fragments. Br. J. Pharmacol. 83, 337-345. doi: 10.1111/j.1476-5381.1984.tb16493.x
21. Johnson, I. M., Kumar, S. G., and Malathi, R. (2003). RNA binding efficacy of theophylline, theobromine and caffeine. J. Biomol. Struct. Dyn. 20, 687-692. doi: 10.1080/07391102.2003.10506885
22. Johnson, I. M., Prakash, H., Prathiba, J., Raghunathan, R., and Malathi, R. (2012). Spectral analysis of naturally occurring methylxanthines (theophylline, theobromine, and caffeine) binding with DNA. PLoS ONE 7:e50019-e50019. doi: 10.1371/journal.pone.0050019
23. Kargul, B., Özcan, M., Peker, S., Nakamoto, T., Simmons, W. B., and Falster, A. U. (2012). Evaluation of human enamel surfaces treated with theobromine: a pilot study. Oral Health Prev. Dent. 10, 275-282. doi: 10.3290/j.ohpd.a28524
24. Khan, N., Monagas, M., Andres-Lacueva, C., Casas, R., Urpí-Sardà, M., Lamuela-Raventós, R. M., et al. (2012). Regular consumption of cocoa powder with milk increases HDL cholesterol and reduces oxidized LDL levels in subjects at high-risk of cardiovascular disease. Nutr. Metab. Cardiovasc. Dis. 22, 1046-1053. doi: 10.1016/j.numecd.2011.02.001
25. Khazan, M., Hedayati, M., Kobarfard, F., Askari, S., and Azizi, F. (2014). Identification and determination of synthetic pharmaceuticals as adulterants in eight common herbal weight loss supplements. Iran. Red Crescent Med. J. 16:e15344. doi: 10.5812/ircmj.15344
26. Klaassen, E. B., De Groot, R. H., Evers, E. A., Snel, J., Veerman, E. C., Ligtenberg, A. J., et al. (2013). The effect of caffeine on working memory load-related brain activation in middle-aged males. Neuropharmacology 64, 160-167. doi: 10.1016/j.neuropharm.2012.06.026
27. Klebanoff, M. A., Zhang, J., Zhang, C., and Levine, R. J. (2009). Maternal serum theobromine and the development of preeclampsia. Epidemiology 20, 727-732. doi: 10.1097/EDE.0b013e3181aba664
28. Kris-Etherton, P. M., Derr, J. A., Mustad, V. A., Seligson, F. H., and Pearson, T. A. (1994). Effects of a milk chocolate bar per day substituted for a high-carbohydrate snack in young men on an NCEP/AHA Step 1 Diet. Am. J. Clin. Nutr. 60, 1037S-1042S.
29. Macnider, W. D. (1917). The efficiency of various diuretics in the acutely nephropathic kidney, protected, and unprotected by sodium carbonate. II. J. Exp. Med. 26, 19-35. doi: 10.1084/jem.26.1.19
30. Maia, L., and de Mendonça, A. (2002). Does caffeine intake protect from Alzheimer's disease? Eur. J. Neurol. 9, 377-382. doi: 10.1046/j.1468-1331.2002.00421.x
31. McPherson, P. S., Kim, Y. K., Valdivia, H., Knudson, C. M., Takekura, H., Franzini-Armstrong, C., et al. (1991). The brain ryanodine receptor: a caffeine-sensitive calcium release channel. Neuron 7, 17-25. doi: 10.1016/0896-6273(91)90070-G
32. Mellor, D. D., Sathyapalan, T., Kilpatrick, E. S., Beckett, S., and Atkin, S. L. (2010). High-cocoa polyphenol-rich chocolate improves HDL cholesterol in Type 2 diabetes patients. Diabet. Med. 27, 1318-1321. doi: 10.1111/j.1464-5491.2010.03108.x
33. Messerli, F. H. (2012). Chocolate consumption, cognitive function, and Nobel laureates. N. Engl. J. Med. 367, 1562-1564. doi: 10.1056/NEJMon1211064
34. Mitchell, E. S., Slettenaar, M., Vd Meer, N., Transler, C., Jans, L., Quadt, F., et al. (2011). Differential contributions of theobromine and caffeine on mood, psychomotor performance and blood pressure. Physiol. Behav. 104, 816-822. doi: 10.1016/j.physbeh.2011.07.027
35. Mokry, J., and Nosalova, G. (2011). The influence of the PDE inhibitors on cough reflex in guinea pigs. Bratisl. Lek. Listy 112, 131-135.
36. Mokry, J., Nosalova, G., and Mokra, D. (2009). Influence of xanthine derivatives on cough and airway reactivity in guinea pigs. J. Physiol. Pharmacol. 60, 87-91.
37. Mogollon, J. A., Boivin, C., Philippe, K., Turcotte, S., Lemieux, S., Blanchet, C., et al. (2013). Consumption of chocolate in pregnant women and risk of preeclampsia: a systematic review. Syst. Rev. 2, 114. doi: 10.1186/2046-4053-2-114
38. Mursu, J., Voutilainen, S., Nurmi, T., Rissanen, T. H., Virtanen, J. K., Kaikkonen, J., et al. (2004). Dark chocolate consumption increases HDL cholesterol concentration and chocolate fatty acids may inhibit lipid peroxidation in healthy humans. Free Radic. Biol. Med. 37, 1351-1359. doi: 10.1016/j.freeradbiomed.2004.06.002
39. National Institute on Drug Abuse. (2014). Commonly Abused Drugs Chart. Available at: http://www.drugabuse.gov/drugs-abuse/commonly-abused-drugs-charts/commonly-abused-drugs-chart (accessed November 5, 2014).
40. Neufingerl, N., Zebregs, Y. E., Schuring, E. A., and Trautwein, E. A. (2013). Effect of cocoa and theobromine consumption on serum HDL-cholesterol concentrations: a randomized controlled trial. Am. J. Clin. Nutr. 97, 1201-1209. doi: 10.3945/ajcn.112.047373
41. Oleaga, C., García, M., Solé, A., Ciudad, C. J., Izquierdo-Pulido, M., and Noé, V. (2012). CYP1A1 is overexpressed upon incubation of breast cancer cells with a polyphenolic cocoa extract. Eur. J. Nutr. 51, 465-476. doi: 10.1007/s00394-011-0231-2
42. Pelligrino, D. A., Xu, H. L., and Vetri, F. (2010). Caffeine and the control of cerebral hemodynamics. J. Alzheimers. Dis. 20(Suppl. 1), S51-S62. doi: 10.3233/JAD-2010-091261
43. Pendleton, M., Brown, S., Thomas, C., and Odle, B. (2012). Potential toxicity of caffeine when used as a dietary supplement for weight loss. J. Diet. Suppl. 9, 293-298. doi: 10.3109/19390211.2012.736460
44. Pendleton, M., Brown, S., Thomas, C. M., and Odle, B. (2013). Potential toxicity of caffeine when used as a dietary supplement for weight loss. J. Diet. Suppl. 10, 1-5. doi: 10.3109/19390211.2012.758215
45. Prieto-Lastra, L., Iglesias-Cadarso, A., Reaño-Martos, M. M., Pérez-Pimiento, A., Rodríguez-Cabreros, M. I., and García-Cubero, A. (2006). Pharmacological stimuli in asthma/urticaria. Allergol. Immunopathol. (Madr) 34, 224-227. doi: 10.1157/13094030
46. Smit, H. J. (2011). Theobromine and the pharmacology of cocoa. Handb. Exp. Pharmacol. 200, 201-234. doi: 10.1007/978-3-642-13443-2_7
47. Smit, H. J., and Blackburn, R. J. (2005). Reinforcing effects of caffeine and theobromine as found in chocolate. Psychopharmacology (Berl) 181, 101-106. doi: 10.1007/s00213-005-2209-3
48. Smit, H. J., Gaffan, E. A., and Rogers, P. J. (2004). Methylxanthines are the psycho-pharmacologically active constituents of chocolate. Psychopharmacology (Berl) 176, 412-419. doi: 10.1007/s00213-004-1898-3
49. Sugimoto, K., Simard, J., Haagensen, D. E., and Labrie, F. (1994). Inverse relationships between cell proliferation and basal or androgen-stimulated apolipoprotein D secretion in LNCaP human prostate cancer cells. J. Steroid Biochem. Mol. Biol. 51, 167-174. doi: 10.1016/0960-0760(94)90090-6
50. Sugimoto, N., Miwa, S., Hitomi, Y., Nakamura, H., Tsuchiya, H., and Yachie, A. (2014). Theobromine, the primary methylxanthine found in Theobroma cacao, prevents malignant glioblastoma proliferation by negatively regulating phosphodiesterase-4, extracellular signal-regulated kinase, Akt/mammalian target of rapamycin kinase, and nuclear factor-kappa B. Nutr. Cancer 66, 419-423. doi: 10.1080/01635581.2013.877497
51. Sunil, V. R., Vayas, K. N., Cervelli, J. A., Malaviya, R., Hall, L., Massa, C. B., et al. (2014). Pentoxifylline attenuates nitrogen mustard-induced acute lung injury, oxidative stress and inflammation. Exp. Mol. Pathol. 97, 89-98. doi: 10.1016/j.yexmp.2014.05.009
52. Tarka, S. M., Arnaud, M. J., Dvorchik, B. H., and Vesell, E. S. (1983). Theobromine kinetics and metabolic disposition. Clin. Pharmacol. Ther. 34, 546-555. doi: 10.1038/clpt.1983.212
53. Tazzeo, T., Bates, G., Roman, H. N., Lauzon, A. M., Khasnis, M. D., Eto, M., et al. (2012). Caffeine relaxes smooth muscle through actin depolymerization. Am. J. Physiol. Lung. Cell Mol. Physiol. 303, L334-L342. doi: 10.1152/ajplung.00103.2012
54. The World Anti-Doping Agency (WADA). (2014). WADA Prohibited List. Available at: http://www.usada.org/substances/prohibited-list (accessed November 10, 2014).
55. Usmani, O. S., Belvisi, M. G., Patel, H. J., Crispino, N., Birrell, M. A., Korbonits, M., et al. (2005). Theobromine inhibits sensory nerve activation and cough. FASEB J. 19, 231-233. doi: 10.1096/fj.04-1990fje
56. van den Bogaard, B., Draijer, R., Westerhof, B. E., Van Den Meiracker, A. H., Van Montfrans, G. A., and Van Den Born, B. J. (2010). Effects on peripheral and central blood pressure of cocoa with natural or high-dose theobromine: a randomized, double-blind crossover trial. Hypertension 56, 839-846. doi: 10.1161/HYPERTENSIONAHA.110.158139
57. Van Zyl, J. M., Derendinger, B., Seifartm, H. I., and Van der Bijl, P. (2008). Comparative diffusion of drugs through bronchial tissue. Int. J. Pharm. 357, 32-36. doi: 10.1016/j.ijpharm.2008.01.028
58. Wagner, E. M., Jenkins, J., Schmieder, A., Eldridge, L., Zhang, Q., Moldobaeva, A., et al. (2015). Angiogenesis and airway reactivity in asthmatic Brown Norway rats. Angiogenesis 18, 1-11. doi: 10.1007/s10456-014-9441-6
59. Wang-Polagruto, J. F., Villablanca, A. C., Polagruto, J. A., Lee, L., Holt, R. R., Schrader, H. R., et al. (2006). Chronic consumption of flavanol-rich cocoa improves endothelial function and decreases vascular cell adhesion molecule in hypercholesterolemic postmenopausal women. J. Cardiovasc. Pharmacol. 47(Suppl. 2), S177-S186; discussion S206-S179. doi: 10.1097/00005344-200606001-00013